SCHEMBL23982374

SCHEMBL23982374

COc1nc(NCc2ccccc2)c2nc[nH]c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 6/20 0.45
▸ PDE4A P27815 1/20 0.45
▸ PDE4B Q07343 1/20 0.45
▸ PDE4C Q08493 1/20 0.45
▸ PDE4D Q08499 1/20 0.45
▸ LMNA P02545 2/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ CDK2 P24941 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ MAPT P10636 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ CDK5 Q00535 1/20 0.42
▸ PDE5A O76074 1/20 0.42
▸ EGFR P00533 5/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17802610 0.84 MAPT (0.47) CDK1CDK2MAPK1MAPTKDM4E
SCHEMBL17802595 0.83 MAPT (0.47) CDK1PDE4APDE4BPDE4CPDE4D
SCHEMBL8009110 0.82 CYP3A4 (0.50) CDK1PDE4APDE4BPDE4CPDE4D
SCHEMBL16146709 0.81 CDK1 (0.54) CDK1PDE4APDE4BPDE4CPDE4D
SCHEMBL8653843 0.80 SMN1; SMN2 (0.49) CDK1PDE4APDE4BPDE4CPDE4D
SCHEMBL20119915 0.80 KMT2A (0.49) CDK1LMNACYP1A2TSHRMAPK1
SCHEMBL16146592 0.80 PDE4A (0.52) CDK1PDE4APDE4BPDE4CPDE4D
SCHEMBL16147165 0.80 CDK1 (0.48) CDK1PDE4APDE4BPDE4CPDE4D
SCHEMBL822377 0.80 CDK1 (0.65) CDK1PDE4APDE4BPDE4CPDE4D
SCHEMBL5997041 0.80 CDK1 (0.48) CDK1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210338706-A1 ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-11-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210338706-A1 ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK PER2, CRY1, ADORA2A CDK1 49/4885PDE4A 10/4885PDE4B 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback